7Baggers

Envista Holdings Corporation
(NYSE:NVST) 

NVST stock logo

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technolo...

Founded: 2018
IPO Price: $22 (Sep 18, 2019)
Full Time Employees: 12,500
CEO: Amir A. Aghdaei  
Sector: Healthcare
Industry: Medical Instruments & Supplies
Medical Devices
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-04-03 2025-12-31 2025-09-26 2025-06-27 2025-03-28 2024-12-31 2024-09-27 2024-06-28 2024-03-29 2023-12-31 2023-09-29 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-07-01 2022-04-01 2021-12-31 2021-10-01 2021-07-02 2021-04-02 2020-12-31 2020-10-02 2020-07-03 2020-04-03 2019-12-31 2019-09-27 
                               
      sales
    		705,500,000 750,600,000 669,900,000 682,100,000 616,900,000 652,900,000 601,000,000 633,100,000 623,600,000 645,600,000 631,300,000 662,400,000 627,200,000 660,800,000 631,100,000 645,800,000 631,400,000 651,800,000 607,300,000 740,100,000 709,200,000 732,300,000 640,500,000 362,000,000 547,200,000  659,300,000 
      cost of sales
    		315,400,000 340,000,000 299,700,000 312,200,000 280,900,000 280,400,000 283,700,000 306,500,000 267,300,000 309,700,000 268,000,000 283,800,000 264,500,000 294,600,000 266,400,000 276,000,000 257,300,000 308,600,000 251,000,000 328,200,000 311,900,000 343,800,000 299,800,000 211,500,000 268,800,000  -292,300,000 
      gross profit
    		390,100,000 410,600,000 370,200,000 369,900,000 336,000,000 372,500,000 317,300,000 326,600,000 356,300,000 335,900,000 363,300,000 378,600,000 362,700,000 366,200,000 364,700,000 369,800,000 374,100,000 343,200,000 356,300,000 411,900,000 397,300,000 388,500,000 340,700,000 150,500,000 278,400,000  367,000,000 
      yoy
    		16.10% 10.23% 16.67% 13.26% -5.70% 10.90% -12.66% -13.73% -1.76% -8.27% -0.38% 2.38% -3.05% 6.70% 2.36% -10.22% -5.84% -11.66% 4.58% 173.69% 42.71%  -7.17%     
      qoq
    		-4.99% 10.91% 0.08% 10.09% -9.80% 17.40% -2.85% -8.34% 6.07% -7.54% -4.04% 4.38% -0.96% 0.41% -1.38% -1.15% 9.00% -3.68% -13.50% 3.67% 2.27% 14.03% 126.38% -45.94%    
      operating expenses:
    		                           
      selling, general and administrative
    		297,600,000 305,200,000 284,400,000 295,300,000 271,700,000 299,700,000 270,900,000 302,500,000 284,900,000 260,200,000 257,700,000 272,900,000 266,100,000 253,600,000 264,200,000 279,500,000 258,200,000 272,300,000 250,600,000 283,100,000 258,900,000 264,600,000 248,800,000 241,900,000 268,700,000   
      research and development
    		30,000,000 32,100,000 28,300,000 28,300,000 25,300,000 26,700,000 25,500,000 23,600,000 23,300,000 20,200,000 22,300,000 26,800,000 24,500,000 24,600,000 26,000,000 25,100,000 24,400,000 24,800,000 24,000,000 30,300,000 30,100,000 27,100,000 22,500,000 16,500,000 34,700,000   
      operating profit
    		62,500,000 73,300,000 57,500,000 46,300,000 39,000,000 46,100,000 20,900,000 -1,153,300,000 48,100,000 -202,800,000 83,300,000 78,900,000 72,100,000 88,000,000 74,500,000 65,200,000 91,500,000 46,100,000 81,700,000 98,500,000 108,300,000 96,800,000 69,400,000 -107,900,000 -25,000,000  78,700,000 
      yoy
    		60.26% 59.00% 175.12% -104.01% -18.92% -122.73% -74.91% -1561.72% -33.29% -330.45% 11.81% 21.01% -21.20% 90.89% -8.81% -33.81% -15.51% -52.38% 17.72% -191.29% -533.20%  -11.82%     
      qoq
    		-14.73% 27.48% 24.19% 18.72% -15.40% 120.57% -101.81% -2497.71% -123.72% -343.46% 5.58% 9.43% -18.07% 18.12% 14.26% -28.74% 98.48% -43.57% -17.06% -9.05% 11.88% 39.48% -164.32% 331.60%    
      nonoperating income:
    		                           
      other expense
    		-2,900,000                           
      interest expense
    		-7,400,000 -10,300,000 -9,000,000 -8,000,000 -9,300,000 -9,900,000 -11,900,000 -11,700,000 -12,900,000 -13,900,000 -15,400,000 -17,400,000 -16,700,000 -14,500,000 -11,600,000 -6,400,000 -5,900,000 -10,500,000 -12,000,000 -13,600,000 -18,000,000 -21,300,000 -23,400,000 -14,500,000 -3,300,000  -200,000 
      income before income taxes
    		52,200,000 57,600,000 49,900,000 40,700,000 29,000,000 36,500,000 9,600,000 -1,166,100,000 35,300,000 -215,000,000 35,800,000 68,600,000 55,700,000 75,700,000 63,200,000 59,100,000 85,900,000 37,200,000 69,900,000 85,200,000 90,600,000 74,200,000 46,200,000 -122,300,000 -28,200,000   
      income tax expense
    		13,500,000 24,700,000 80,200,000 14,300,000 11,000,000 35,300,000 1,400,000 -14,500,000 11,700,000 2,400,000 14,300,000 16,700,000 11,900,000 2,200,000 13,600,000 14,600,000 15,500,000 -5,300,000 -10,300,000 -4,900,000 18,900,000 -34,200,000 10,600,000 -28,800,000 -11,000,000   
      net income
    		38,700,000 32,900,000 -30,300,000 26,400,000 18,000,000 1,200,000 8,200,000 -1,151,600,000 23,600,000 -217,400,000 21,500,000 51,900,000 43,800,000 73,500,000 47,600,000 47,100,000 74,900,000 85,800,000 92,900,000 90,100,000 71,700,000 108,400,000 35,600,000 -93,500,000 -17,200,000   
      yoy
    		115.00% 2641.67% -469.51% -102.29% -23.73% -100.55% -61.86% -2318.88% -46.12% -395.78% -54.83% 10.19% -41.52% -14.34% -48.76% -47.72% 4.46% -20.85% 160.96% -196.36% -516.86%       
      qoq
    		17.63% -208.58% -214.77% 46.67% 1400.00% -85.37% -100.71% -4979.66% -110.86% -1111.16% -58.57% 18.49% -40.41% 54.41% 1.06% -37.12% -12.70% -7.64% 3.11% 25.66% -33.86% 204.49% -138.07% 443.60%    
      earnings per share:
    		                           
      earnings - basic
    		0.24 0.2 -0.18  0.1   -6.69 0.14 -1.31 0.13 0.32 0.27 0.45 0.29 0.29 0.46 0.53 0.58         
      earnings - diluted
    		0.23 0.2 -0.18 0.16 0.1   -6.69 0.14 -1.26 0.12 0.29 0.25 0.42 0.27 0.26 0.42 0.49 0.52         
      average common stock and common equivalent shares outstanding:
    		                           
      basic
    		163.9 -1.2 166.1 169 172.4 0.1 172.2 172.1 171.9 1.6 168.2 164 163.6 0.2 163.1 162.9 162.2 0.1 161.5 161.2 160.5 0.2 159.7    130.6 
      diluted
    		166.4 -1.1 166.1 169.9 173.6 0.1 172.9 172.1 173.4 -9.4 175.2 176.3 177.4 -0.8 176.9 178.5 179.8 0.1 178.1 178.4 175.9 4.7 163.9    130.6 
      goodwill and intangible asset impairment
    		       1,153,800,000                    
      other income
    		 775,000 1,400,000 2,400,000 -700,000 300,000 600,000 -1,100,000 100,000 1,700,000 -32,100,000 7,100,000 300,000 2,200,000 300,000 300,000 300,000 1,600,000 200,000 300,000 300,000 -1,300,000 200,000 100,000 100,000  200,000 
      earnings- basic
    		   0.16                        
      earnings earnings - basic
    		     -1.628 0.05                     
      earnings earnings - diluted
    		     -1.628 0.05                     
      income from continuing operations, net of tax
    		         -217,400,000 21,500,000 51,900,000 43,800,000 73,500,000 49,600,000 44,500,000 70,400,000           
      income from discontinued operations, net of tax
    		              -2,000,000 2,600,000 4,500,000 43,300,000 12,700,000         
      earnings from continuing operations - basic
    		         -1.31 0.13 0.32 0.27 0.45 0.3 0.27 0.43 0.26 0.5         
      earnings from continuing operations - diluted
    		         -1.26 0.12 0.29 0.25 0.42 0.28 0.25 0.39 0.23 0.45         
      earnings from discontinued operations - basic
    		              -0.01 0.02 0.03 0.27 0.08         
      earnings from discontinued operations - diluted
    		             0.008 -0.01 0.01 0.03 0.24 0.07         
      * earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. the sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.
    		                           
      income from continuing operations
    		                 55,250,000 80,200,000         
      earnings per share:
    		                           
      basic
    		                   0.56 0.45 0.68 0.22     
      diluted
    		                   0.51 0.41 0.67 0.22     
      earnings per share:
    		                           
      basic and diluted
    		                       -0.59 -0.11   
      average common stock and common equivalent shares outstanding:
    		                           
      basic and diluted
    		                       159.5 159.2   
      operating costs:
    		                           
      selling, general and administrative expenses
    		                          -252,000,000 
      research and development expenses
    		                          -36,300,000 
      earnings before income taxes
    		                          78,700,000 
      income taxes
    		                          -16,600,000 
      net earnings
    		                          62,100,000 
      net earnings per share:
    		                           
      basic
    		                          0.48 
      diluted
    		                          0.48 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-04-03 2025-12-31 2025-09-26 2025-06-27 2025-03-28 2024-12-31 2024-09-27 2024-06-28 2024-03-29 2023-12-31 2023-09-29 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-07-01 2022-04-01 2021-12-31 2021-10-01 2021-07-02 2021-04-02 2020-12-31 2020-10-02 2020-07-03 2020-04-03 2019-12-31 2019-09-27 
                                 
        assets
      		                           
        current assets:
      		                           
        cash and cash equivalents
      		1,082,800,000 1,211,700,000 1,133,900,000 1,110,600,000 1,077,300,000 1,069,100,000 991,300,000 1,036,200,000 948,500,000 940,000,000 824,200,000 651,700,000 585,200,000 606,900,000 568,500,000 523,100,000 1,078,300,000 1,073,600,000 638,800,000 553,900,000        
        trade accounts receivable, less allowance for credit losses of 23.7 and 22.5, respectively
      		436,600,000                           
        inventories
      		300,300,000 288,100,000 290,800,000 281,900,000 261,300,000 241,000,000 265,600,000 263,800,000 267,400,000 258,800,000 278,800,000 297,000,000 307,200,000 300,800,000 291,300,000 286,000,000 280,400,000 263,800,000 274,300,000 311,500,000 283,200,000 266,900,000 257,500,000 280,800,000 312,300,000 277,900,000  
        prepaid expenses and other current assets
      		99,400,000 97,200,000 117,700,000 119,600,000 118,000,000 115,200,000 148,000,000 141,300,000 143,000,000 137,400,000 120,600,000 125,000,000 120,100,000 123,400,000 114,000,000 202,300,000 197,400,000 154,300,000 77,900,000 81,300,000 80,800,000 73,700,000 92,500,000 108,100,000 82,400,000 69,200,000 50,500,000 
        total current assets
      		1,919,100,000 2,026,600,000 1,948,300,000 1,934,900,000 1,849,700,000 1,788,300,000 1,797,000,000 1,821,900,000 1,771,900,000 1,743,700,000 1,640,700,000 1,488,900,000 1,414,300,000 1,424,600,000 1,366,000,000 1,388,300,000 1,908,900,000 1,835,800,000 1,766,400,000 1,301,700,000 1,163,300,000 1,590,500,000 1,416,200,000 1,517,700,000 1,114,200,000 1,001,900,000 978,500,000 
        property, plant and equipment
      		298,700,000 296,800,000 288,400,000 287,000,000 279,700,000 277,000,000 291,500,000 290,800,000 306,200,000 309,600,000 304,000,000 300,100,000 297,600,000 293,600,000 277,200,000 264,100,000 264,200,000 264,100,000 266,100,000 303,900,000 295,700,000 303,000,000 296,800,000 294,300,000 289,500,000 290,300,000  
        operating lease right-of-use assets
      		143,600,000 142,100,000 148,000,000 141,900,000 138,700,000 142,800,000 141,700,000 125,000,000 125,300,000 125,100,000 126,600,000 129,600,000 132,900,000 131,800,000 132,100,000 130,500,000 127,000,000 128,100,000 150,800,000 153,900,000 155,500,000 165,300,000 177,100,000 188,900,000 193,100,000 200,100,000  
        other long-term assets
      		223,800,000 228,100,000 249,300,000 264,900,000 244,700,000 230,600,000 250,600,000 218,600,000 174,400,000 180,500,000 152,900,000 151,700,000 158,300,000 153,700,000 173,200,000 212,400,000 174,900,000 167,800,000 174,100,000 147,000,000 127,000,000 127,300,000 72,700,000 75,200,000 93,000,000 74,400,000 282,500,000 
        goodwill
      		2,359,800,000 2,358,200,000 2,362,700,000 2,369,600,000 2,303,400,000 2,261,900,000 2,333,800,000 2,283,700,000 3,259,800,000 3,292,200,000 3,458,200,000 3,493,800,000 3,506,400,000 3,496,600,000 3,399,600,000 3,389,700,000 3,090,500,000 3,132,000,000 3,145,800,000 3,381,900,000 3,372,800,000 3,430,700,000 3,380,400,000 3,333,800,000 3,292,500,000 3,306,000,000 3,283,200,000 
        other intangible assets
      		633,000,000 627,200,000 645,800,000 666,100,000 650,200,000 649,900,000 696,100,000 698,100,000 918,700,000 954,000,000 1,001,400,000 1,043,100,000 1,065,500,000 1,086,700,000 1,063,800,000 1,076,000,000 1,006,800,000 1,046,400,000 1,058,800,000 1,192,900,000 1,207,600,000 1,259,200,000 1,262,500,000 1,255,300,000 1,258,600,000 1,285,600,000 1,291,100,000 
        total assets
      		5,578,000,000 5,679,000,000 5,642,500,000 5,664,400,000 5,466,400,000 5,350,500,000 5,510,700,000 5,438,100,000 6,556,300,000 6,605,100,000 6,683,800,000 6,607,200,000 6,575,000,000 6,587,000,000 6,411,900,000 6,461,000,000 6,572,300,000 6,574,200,000 6,562,000,000 6,481,300,000 6,321,900,000 6,876,000,000 6,605,700,000 6,665,200,000 6,240,900,000 6,158,300,000 6,118,400,000 
        liabilities and equity
      		                           
        current liabilities:
      		                           
        trade accounts payable
      		170,000,000 191,600,000 156,000,000 171,800,000 163,500,000 174,600,000 172,100,000 172,400,000 174,700,000 179,500,000 168,600,000 176,800,000 186,800,000 228,300,000 190,000,000 182,700,000 180,600,000 185,800,000 171,000,000 209,400,000 204,600,000 235,100,000 161,100,000 130,900,000 194,800,000 208,000,000 181,400,000 
        accrued expenses and other liabilities
      		577,900,000 622,000,000 626,500,000 586,000,000 558,800,000 553,600,000 541,400,000 498,800,000 458,600,000 455,700,000 433,700,000 434,000,000 423,600,000 471,400,000 462,500,000 539,400,000 541,400,000 562,300,000 509,900,000 504,800,000 488,000,000 530,300,000 485,900,000 419,400,000 383,900,000 470,600,000 571,800,000 
        operating lease liabilities
      		38,700,000 39,000,000 39,200,000 36,100,000 34,800,000 34,500,000 36,200,000 34,500,000 32,500,000 30,300,000 29,400,000 28,500,000 28,400,000 27,000,000 26,500,000 23,800,000 23,500,000 23,700,000 24,500,000 27,500,000 27,300,000 32,500,000 28,100,000 26,400,000 26,700,000 26,700,000  
        total current liabilities
      		786,600,000 852,600,000 821,700,000 793,900,000 873,300,000 878,700,000 865,500,000 821,400,000 781,300,000 780,800,000 746,800,000 1,150,800,000 1,149,600,000 1,236,700,000 1,258,300,000 1,256,200,000 1,255,700,000 1,208,200,000 1,269,200,000 1,163,200,000 1,136,300,000 1,684,700,000 678,900,000 830,200,000 608,900,000 709,200,000 760,700,000 
        other long-term liabilities
      		161,400,000 161,400,000 169,700,000 171,400,000 147,500,000 139,800,000 149,700,000 147,500,000 136,700,000 142,400,000 150,500,000 153,000,000 151,300,000 151,300,000 220,700,000 201,300,000 288,200,000 304,200,000 318,200,000 415,300,000 403,600,000 408,800,000 445,000,000 440,900,000 419,500,000 399,300,000 539,200,000 
        long-term debt
      		1,439,100,000 1,448,300,000 1,445,400,000 1,445,100,000 1,295,800,000 1,278,300,000 1,305,600,000 1,388,700,000 1,390,500,000 1,398,100,000 1,381,000,000 875,600,000 873,800,000 870,700,000 851,600,000 864,100,000 876,900,000 883,400,000 887,800,000 893,200,000 892,200,000 907,700,000 1,755,500,000 1,722,200,000 1,546,700,000 1,321,000,000 1,304,500,000 
        commitments and contingencies
      		                           
        stockholders’ equity:
      		                           
        preferred stock, 0.01 par value...
      		                           
        common stock, 0.01 par value...
      		1,800,000 1,800,000 1,800,000 1,700,000 1,700,000 1,700,000 1,700,000 1,700,000 1,700,000                   
        treasury stock
      		-273,500,000 -224,500,000 -199,000,000 -156,500,000 -73,100,000                       
        additional paid-in capital
      		3,896,000,000 3,882,600,000 3,871,800,000 3,860,300,000 3,850,000,000 3,791,600,000 3,783,000,000 3,773,400,000 3,767,400,000 3,758,200,000 3,749,700,000 3,719,200,000 3,712,800,000 3,699,000,000 3,689,600,000 3,678,400,000 3,667,900,000 3,732,600,000 3,716,600,000 3,707,600,000 3,691,100,000 3,684,400,000 3,674,200,000 3,665,900,000 3,596,100,000 3,589,700,000 3,613,600,000 
        accumulated deficit
      		-401,700,000 -440,400,000 -473,300,000 -443,000,000 -469,400,000                       
        accumulated other comprehensive loss
      		-143,100,000 -113,200,000 -113,100,000 -123,500,000 -273,100,000 -371,100,000 -223,600,000 -301,600,000 -283,600,000 -217,200,000 -306,800,000 -236,900,000 -210,600,000 -225,100,000 -391,200,000 -274,300,000 -201,800,000 -143,500,000 -152,600,000 -128,900,000 -143,900,000 -91,800,000 -136,200,000 -156,500,000 -189,900,000 -144,200,000 -140,900,000 
        total stockholders’ equity
      		3,079,500,000 3,106,300,000 3,088,200,000 3,139,000,000 3,036,100,000 2,934,800,000 3,072,500,000 2,976,700,000 4,140,300,000 4,173,900,000 4,293,200,000 4,311,000,000 4,279,000,000 4,206,900,000 3,957,900,000 4,016,000,000 4,030,900,000 4,058,000,000 3,947,100,000 3,868,900,000 3,747,300,000 3,721,000,000 3,559,800,000 3,495,900,000    
        total liabilities and stockholders’ equity
      		5,578,000,000 5,679,000,000 5,642,500,000 5,664,400,000 5,466,400,000 5,350,500,000 5,510,700,000 5,438,100,000 6,556,300,000 6,605,100,000 6,683,800,000 6,607,200,000 6,575,000,000 6,587,000,000 6,411,900,000 6,461,000,000 6,572,300,000 6,574,200,000 6,562,000,000 6,481,300,000 6,321,900,000 6,876,000,000 6,605,700,000 6,665,200,000    
        trade accounts receivable, less allowance for credit losses of 22.5 and 26.6, respectively
      		 429,600,000                          
        short-term debt
      		    116,200,000 116,000,000 115,800,000 115,700,000 115,500,000 115,300,000 115,100,000 511,500,000 510,800,000 510,000,000 579,300,000 508,600,000 507,800,000 432,400,000 426,700,000 421,500,000 416,400,000 886,800,000 3,800,000 253,500,000 3,500,000 3,900,000 7,500,000 
        trade accounts receivable, less allowance for credit losses of 21.8 and 26.6, respectively
      		  405,900,000                         
        trade accounts receivable, less allowance for credit losses of 23.1 and 26.6, respectively
      		   422,800,000                        
        trade accounts receivable, less allowance for credit losses of 26.6 and 26.6, respectively
      		    393,100,000                       
        trade accounts receivable, less allowance for credit losses of 26.6 and 17.3, respectively
      		     363,000,000                      
        accumulated (deficit) earnings
      		     -487,400,000 -488,600,000 -496,800,000                    
        trade accounts receivable, less allowance for credit losses of 28.0 and 17.3, respectively
      		      392,100,000                     
        trade accounts receivable, less allowance for credit losses of 27.7 and 17.3, respectively
      		       380,600,000                    
        trade accounts receivable, less allowance for credit losses of 19.8 and 17.3, respectively
      		        413,000,000                   
        retained earnings
      		        654,800,000 631,200,000 848,600,000 827,100,000 775,200,000 731,400,000 657,900,000 610,300,000 563,200,000 466,900,000 381,100,000 288,200,000 198,100,000 126,400,000 18,000,000  75,900,000 93,100,000 37,000,000 
        trade accounts receivable, less allowance for credit losses of 17.3 and 16.2, respectively
      		         407,500,000                  
        common stock - 0.01 par value...
      		         1,700,000 1,700,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 
        trade accounts receivable, less allowance for credit losses of 16.0 and 16.2, respectively
      		          417,100,000  401,800,000               
        trade accounts receivable, less allowance for credit losses of 16.3 and 16.2, respectively
      		           415,200,000                
        trade accounts receivable, less allowance for credit losses of 16.2 and 20.7, respectively
      		             393,500,000              
        assets held for sale
      		               4,100,000 10,200,000           
        liabilities held for sale
      		               1,700,000 2,400,000           
        total envista stockholders’ equity
      		             4,206,900,000 3,957,900,000 4,016,000,000 4,030,900,000 4,057,600,000 3,946,700,000 3,868,500,000 3,746,900,000 3,720,600,000 3,557,600,000 3,493,400,000    
        noncontrolling interests
      		                 400,000 400,000 400,000 400,000 400,000 2,200,000 2,500,000 2,600,000 2,600,000 2,700,000 
        trade accounts receivable, less allowance for credit losses of 16.8 and 20.7, respectively
      		              392,200,000             
        trade accounts receivable, less allowance for credit losses of 19.6 and 20.7, respectively
      		               372,800,000            
        trade accounts receivable, less allowance for credit losses of 20.3 and 20.7, respectively
      		                342,600,000           
        trade accounts receivable, less allowance for credit losses of 20.7 and 30.5, respectively
      		                 331,900,000          
        current assets held for sale
      		                 12,200,000 468,000,000         
        noncurrent assets held for sale
      		                           
        current liabilities held for sale
      		                 4,000,000 137,100,000         
        noncurrent liabilities held for sale
      		                           
        trade accounts receivable, less allowance for credit losses of 25.2 and 30.5, respectively
      		                  307,400,000         
        preferred stock, no par value, 15.0 million shares authorized; no shares issued or outstanding at october 1, 2021 and december 31, 2020
      		                           
        trade accounts receivable, less allowance for credit losses of 32.8 and 37.1, respectively
      		                   355,000,000        
        preferred stock, no par value, 15.0 million shares authorized; no shares issued or outstanding at july 2, 2021 and december 31, 2020
      		                           
        cash and equivalents
      		                    441,200,000 888,900,000 700,800,000 822,400,000 353,600,000 211,200,000 193,200,000 
        trade accounts receivable, less allowance for credit losses of 34.9 and 37.1, respectively
      		                    358,100,000       
        preferred stock, no par value, 15.0 million shares authorized; no shares issued or outstanding at april 2, 2021 and december 31, 2020
      		                           
        trade accounts receivable, less allowance for credit losses of 37.1 and 22.8, respectively
      		                     361,000,000      
        preferred stock, no par value, 15.0 million shares authorized; no shares issued or outstanding at december 31, 2020 and december 31, 2019
      		                           
        trade accounts receivable, less allowance for credit losses of 35.8 and 22.8, respectively
      		                      365,400,000     
        preferred stock, no par value, 15.0 million shares authorized; no shares issued or outstanding at october 2, 2020 and december 31, 2019
      		                           
        trade accounts receivable, less allowance for credit losses of 30.6 and 22.8, respectively
      		                       306,400,000    
        preferred stock, no par value, 15.0 million shares authorized; no shares issued or outstanding at july 3, 2020 and december 31, 2019
      		                           
        (accumulated deficit) retained earnings
      		                       -17,600,000    
        trade accounts receivable, less allowance for credit losses of 26.6 and 22.8, respectively
      		                        365,900,000   
        equity:
      		                           
        preferred stock, no par value, 15.0 million shares authorized; no shares issued or outstanding at april 3, 2020 and december 31, 2019
      		                           
        total envista equity
      		                        3,483,700,000 3,540,200,000 3,511,300,000 
        total equity
      		                        3,486,300,000 3,542,800,000 3,514,000,000 
        total liabilities and equity
      		                        6,240,900,000 6,158,300,000 6,118,400,000 
        trade accounts receivable, less allowance for doubtful accounts of 22.8 and 17.9, respectively
      		                         443,600,000  
        preferred stock, no par value, 15.0 million shares authorized; no shares issued or outstanding at december 31, 2019 and december 31, 2018
      		                           
        former parent investment
      		                           
        trade accounts receivable
      		                          456,400,000 
        inventories:
      		                           
        finished goods
      		                          176,500,000 
        work in process
      		                          31,700,000 
        raw materials
      		                          70,200,000 
        total inventories
      		                          278,400,000 
        property, plant and equipment, net of accumulated depreciation
      		                          283,100,000 
        preferred stock, without par value, 15.0 million shares authorized; no shares issued or outstanding at september 27, 2019 and december 31, 2018
      		                           
        net parent investment
      		                           
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-09-26 2025-06-27 2025-03-28 2024-12-31 2024-09-27 2024-06-28 2024-03-29 2023-12-31 2023-09-29 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-07-01 2022-04-01 2021-12-31 2021-10-01 2021-07-02 2021-04-02 2020-12-31 2020-10-02 2020-07-03 2020-04-03 
                               
          cash flows from operating activities:
        		                       
          net income
        		-30,300,000 26,400,000 18,000,000 1,200,000 8,200,000 -1,151,600,000 23,600,000 -217,400,000 21,500,000 51,900,000 43,800,000 73,500,000 47,600,000 47,100,000 74,900,000 85,800,000 92,900,000 90,100,000 71,700,000 108,400,000 35,600,000 -93,500,000 -17,200,000 
          noncash items:
        		                       
          depreciation
        		10,100,000 10,800,000 9,100,000 9,200,000 10,500,000 11,600,000 9,500,000 9,200,000 8,900,000 9,400,000 8,500,000 7,900,000 7,800,000 8,300,000 7,800,000 11,400,000 9,500,000 9,600,000 10,300,000 10,900,000 11,900,000 10,100,000 9,500,000 
          amortization
        		19,100,000 19,000,000 18,800,000 18,600,000 18,700,000 22,400,000 22,600,000 23,700,000 23,900,000 24,100,000 27,900,000 27,800,000 27,900,000 26,800,000 23,500,000 20,200,000 20,600,000 21,000,000 21,000,000 22,200,000 22,700,000 22,800,000 22,500,000 
          allowance for credit losses
        		2,000,000 2,700,000 1,300,000 1,900,000 2,200,000 9,300,000 4,500,000 3,600,000 300,000 1,200,000 2,000,000 1,000,000 200,000 1,900,000 1,700,000 1,400,000 600,000 700,000 2,900,000     
          stock-based compensation expense
        		10,400,000 9,700,000 7,100,000 9,200,000 9,800,000 5,300,000 11,000,000 4,500,000 6,000,000 5,200,000 15,000,000 7,400,000 7,300,000 8,300,000 7,500,000 6,600,000 7,300,000 7,900,000 6,400,000 5,900,000 5,000,000 5,700,000 6,000,000 
          gain on investments in rabbi trust
        		-1,400,000                       
          loss on equity investments
        		                       
          loss on sale of property, plant and equipment
        		0                       
          goodwill and intangible asset impairments
        		   0 0                   
          fixed assets impairments and other charges
        		800,000   0 0                   
          non-cash operating lease costs
        		8,600,000 8,800,000 8,400,000 8,300,000 8,100,000                   
          amortization of debt discount and issuance costs
        		1,000,000 1,100,000 1,100,000 1,200,000 1,400,000 1,100,000 1,200,000 1,200,000 1,300,000 1,100,000 1,000,000 1,100,000 1,000,000 1,000,000 1,000,000 5,700,000 5,600,000 5,800,000 6,200,000 5,400,000 5,300,000   
          deferred income taxes
        		26,300,000   17,800,000 -700,000                   
          change in trade accounts receivable
        		13,600,000 -15,900,000 -21,300,000 10,900,000 -6,000,000 21,400,000 -16,300,000 16,000,000 -9,000,000 -15,500,000 -8,500,000 5,500,000 -19,900,000 -40,400,000 -16,200,000 -28,100,000 -13,600,000 3,600,000 -5,100,000 7,600,000 -61,800,000 53,100,000 73,000,000 
          change in inventories
        		-11,100,000 -13,400,000 -10,100,000 15,200,000 -600,000 1,200,000 -12,200,000 25,700,000 13,300,000 3,200,000 -7,100,000 -4,000,000 -6,400,000 -9,200,000 -20,300,000 1,100,000 -19,200,000 -27,500,000 -20,400,000 -4,900,000 26,200,000 27,300,000 -36,700,000 
          change in trade accounts payable
        		-15,900,000 5,100,000 -15,100,000 6,300,000 -2,500,000 -2,300,000 -2,700,000 6,900,000 -6,100,000 -9,000,000 -38,100,000 33,200,000 5,400,000 8,400,000 -2,500,000 19,600,000 -16,400,000 4,100,000 -27,600,000 70,900,000 27,800,000 -66,400,000 -10,700,000 
          change in prepaid expenses and other assets
        		5,800,000 3,500,000 -7,800,000 6,200,000 -9,200,000 100,000 -3,800,000 -2,100,000 6,500,000 -2,400,000 1,300,000 10,000,000 -4,300,000 -600,000 -16,800,000 11,900,000 -16,200,000 700,000 -7,900,000 31,300,000 -30,800,000 -14,400,000 11,400,000 
          change in accrued expenses and other liabilities
        		50,500,000 43,700,000 800,000 35,000,000 42,800,000 52,400,000 4,300,000 14,100,000 1,100,000 14,100,000 -41,300,000 -23,300,000 -28,800,000 -29,400,000 -51,500,000 53,000,000 15,500,000 3,700,000 -37,900,000 10,800,000 90,000,000 28,000,000 -118,800,000 
          change in operating lease liabilities
        		-10,600,000 -11,400,000 -10,800,000 -11,300,000 -11,400,000 -10,800,000 -9,300,000 -8,900,000 -8,800,000 -8,500,000 -8,300,000 -8,200,000 -7,900,000 -7,500,000 -8,000,000 -8,400,000 -8,400,000 -8,600,000 -12,100,000 -9,500,000 -9,100,000 -9,000,000 -9,100,000 
          net cash from operating activities
        		78,700,000 88,700,000 300,000 132,400,000 70,700,000 93,100,000 40,300,000 102,000,000 95,500,000 75,100,000 3,100,000 110,300,000 46,700,000 22,200,000 3,500,000 136,000,000 88,300,000 120,700,000 16,600,000 193,400,000 148,100,000 4,700,000 -62,300,000 
          capital expenditures
        		0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
          free cash flows
        		78,700,000 88,700,000 300,000 132,400,000 70,700,000 93,100,000 40,300,000 102,000,000 95,500,000 75,100,000 3,100,000 110,300,000 46,700,000 22,200,000 3,500,000 136,000,000 88,300,000 120,700,000 16,600,000 193,400,000 148,100,000 4,700,000 -62,300,000 
          cash flows from investing activities:
        		                       
          payments for additions to property, plant and equipment
        		-10,800,000 -12,300,000 -5,900,000 -8,600,000 -7,400,000 -6,800,000 -11,000,000 -8,200,000 -18,400,000 -14,100,000 -17,500,000 -16,900,000 -26,900,000 -12,100,000 -19,800,000 -8,700,000 -17,500,000 -20,200,000 -8,300,000 -13,100,000 -13,200,000 -7,800,000 -13,600,000 
          purchases of investments held in rabbi trust
        		-8,600,000 -300,000 -700,000 -200,000                    
          proceeds from sale of investments held in rabbi trust
        		9,000,000 200,000 700,000 500,000                    
          proceeds from sales of property, plant and equipment
        		0 0 500,000         1,700,000    0        
          proceeds from sale of equity investment
        		   0 0   0 0               
          all other investing activities
        		700,000 -4,700,000 -3,400,000 -1,700,000 600,000 500,000 300,000 -11,000,000 -7,700,000 600,000 -4,500,000 -100,000 -4,900,000 -8,500,000 -5,100,000 -13,100,000 2,800,000 2,900,000 2,800,000 2,700,000 3,600,000 3,900,000 3,800,000 
          net cash from investing activities
        		-9,700,000 -17,100,000 -8,800,000 -7,400,000 -30,600,000 -5,900,000 -10,700,000 -12,600,000 -25,000,000 -2,800,000 -22,000,000 -1,100,000 -69,700,000 -591,600,000 5,100,000  -3,100,000 -17,300,000 -5,500,000 -5,100,000 -9,600,000 -3,000,000 -51,400,000 
          cash flows from financing activities:
        		                       
          proceeds from stock option exercises
        		1,000,000 700,000 800,000 400,000 100,000 600,000 1,300,000 3,800,000 1,600,000 1,300,000 4,600,000 1,900,000 4,500,000 2,300,000 13,100,000 3,500,000 2,200,000 8,500,000 5,300,000 5,100,000 3,700,000 1,700,000 3,300,000 
          cash paid for treasury stock
        		-42,000,000 -85,700,000 -14,600,000                     
          tax withholding payment related to net settlement of equity awards
        		-700,000 -500,000 -3,800,000 -1,300,000 -600,000 -100,000 -3,300,000 -100,000 -1,400,000 -300,000 -6,100,000 -200,000 -800,000 -500,000 -7,600,000         
          repayment of convertible notes due 2025
        		0                       
          repayment of borrowings
        		   0    0      0 -500,000 0 -100,000 -100,000 -475,500,000   0 -100,000 
          proceeds from revolving line of credit
        		0           0        0 0   
          all other financing activities
        		   0 0 -200,000 -600,000 -100,000 -1,400,000       -1,700,000 -6,400,000 0 1,000,000 -1,300,000 1,700,000 -6,600,000 5,500,000 
          net cash from financing activities
        		-41,700,000 -86,400,000 -17,600,000 -900,000 -100,500,000 300,000 -2,600,000 3,300,000 114,500,000 2,600,000 -1,500,000 -68,300,000 73,700,000 1,800,000 5,300,000 1,800,000 -4,300,000 6,500,000 -469,600,000    258,500,000 
          effect of exchange rate changes on cash and cash equivalents
        		-4,000,000 48,100,000 34,300,000 -46,300,000 15,500,000 200,000 -18,500,000 23,100,000 -12,500,000 -8,400,000 -1,300,000 -2,500,000 -5,300,000 12,400,000 -9,200,000 8,400,000 4,000,000       
          net change in cash and cash equivalents
        		23,300,000 33,300,000 8,200,000 77,800,000 -44,900,000 87,700,000 8,500,000 115,800,000 172,500,000 66,500,000 -21,700,000 38,400,000 45,400,000 -555,200,000 4,700,000 434,800,000 84,900,000       
          beginning balance of cash and cash equivalents
        		0 0 1,069,100,000 0 0 0 940,000,000 0 0 0 606,900,000 0 0 0 1,073,600,000 0 0       
          ending balance of cash and cash equivalents
        		23,300,000 33,300,000 1,077,300,000 77,800,000 -44,900,000 87,700,000 948,500,000 115,800,000 172,500,000 66,500,000 585,200,000 38,400,000 45,400,000 -555,200,000 1,078,300,000 434,800,000 84,900,000       
          supplemental data:
        		                       
          cash paid for interest
        		4,000,000 9,700,000 13,400,000 9,300,000 15,900,000 12,800,000 16,700,000 15,300,000 12,600,000 21,000,000 14,300,000 17,300,000 7,300,000 11,000,000 2,800,000   11,600,000 10,500,000 22,400,000 17,500,000 13,900,000 2,900,000 
          cash paid for taxes
        		20,900,000 16,400,000 5,200,000 3,100,000 13,900,000 12,100,000 3,800,000 49,100,000 16,000,000 26,900,000 6,600,000 39,000,000   14,100,000   45,400,000 5,700,000 6,300,000 8,100,000 3,600,000 10,600,000 
          rou assets obtained in exchange for operating lease obligations
        		15,600,000 7,800,000 1,200,000 10,300,000 25,000,000 8,000,000 11,500,000 3,200,000 6,800,000 4,500,000 7,600,000 6,400,000   7,100,000   8,200,000 2,600,000 12,100,000 11,700,000 3,500,000 800,000 
          restructuring charges
        		 0 200,000    -200,000 600,000 -100,000 700,000 100,000 -800,000 1,700,000 5,700,000 -1,900,000 10,500,000 0   0 2,100,000   
          loss on investments in rabbi trust
        		  600,000                     
          treasury stock purchases in accrued liabilities
        		  4,300,000                     
          gain on equity investments
        		   -100,000 -600,000   0                
          gain on sale of property, plant and equipment
        		       -3,400,000    -800,000 0   0        
          gain on sale of kavo treatment unit and instrument business
        		           0 0 -2,900,000 -6,000,000         
          fair value adjustment of acquisition-related inventory
        		                       
          inducement expense related to exchange of convertible notes
        		       0                
          acquisitions, net of cash acquired
        		                   0 0 900,000 -41,600,000 
          proceeds from sale of kavo treatment unit and instrument business
        		           14,100,000 31,000,000 -1,200,000 30,000,000         
          proceeds from the settlement of derivative financial instruments
        		       500,000    100,000            
          proceeds from issuance of convertible notes due 2028
        		       0                
          debt issuance costs related to issuance of convertible notes due 2028
        		       -300,000                
          principal paid related to exchange of convertible notes due 2025
        		       0                
          proceeds from borrowings
        		       0      0 300,000        249,800,000 
          debt issuance costs related to other borrowings
        		       0                
          repayment of revolving line of credit
        		           -70,000,000        0    
          impairment charges
        		      800,000  100,000 -100,000 300,000 600,000 900,000 1,000,000 3,900,000 9,000,000 5,300,000 2,200,000 1,900,000 15,500,000 6,800,000   
          amortization of right-of-use assets
        		      7,300,000 7,100,000 6,800,000 6,600,000 6,500,000 6,600,000 6,500,000 4,800,000 6,400,000 7,000,000 7,000,000 7,100,000 7,200,000 7,400,000 7,900,000 7,400,000 7,800,000 
          other impairment charges
        		                       
          change in deferred income taxes
        		                       
          gain on sale of equity investment
        		                       
          proceeds from borrowing
        		           0            
          repayment of borrowing
        		           0            
          proceeds from issuance of convertible senior notes
        		                   0 0   
          payment of debt issuance and other deferred financing costs
        		               0 0 -1,900,000 -400,000 0 100,000   
          purchase of capped calls related to issuance of convertible senior notes
        		                   0 0   
          fair value of acquisition-related inventory
        		                       
          acquisition, net of cash acquired
        		            -126,400,000           
          net cash from (used) in investing activities
        		                       
          proceeds from the public offering of common stock, net of issuance costs
        		                       
          consideration to former parent in connection with the separation
        		                       
          net transfers to former parent
        		                       
          effect of exchange rate changes on cash and equivalents
        		                  10,800,000 -4,000,000 -15,700,000 -7,500,000 -2,400,000 
          net change in cash and equivalents
        		                  -447,700,000 188,100,000 -121,600,000 468,800,000 142,400,000 
          beginning balance of cash and equivalents
        		                  888,900,000 0 0 0 211,200,000 
          ending balance of cash and equivalents
        		                  441,200,000 188,100,000 -121,600,000 468,800,000 353,600,000 
          assets acquired:
        		                       
          cash
        		                  2,900,000   0 2,900,000 
          trade accounts receivable
        		                  1,000,000   0 1,000,000 
          inventories
        		                  1,900,000   0 1,900,000 
          prepaid expenses and other current assets
        		                  200,000   0 200,000 
          property, plant and equipment
        		                  500,000   0 500,000 
          goodwill
        		                  25,100,000   -800,000 25,200,000 
          other intangible assets
        		                  22,300,000   0 22,300,000 
          total assets acquired
        		                  53,900,000   -800,000 54,000,000 
          liabilities assumed:
        		                       
          trade accounts payable
        		                  -100,000   0 -100,000 
          accrued expenses and other liabilities
        		                  -10,200,000   0 -9,400,000 
          total liabilities assumed
        		                  -10,300,000   0 -9,500,000 
          total net assets acquired
        		                  43,600,000   -800,000 44,500,000 
          allowance for doubtful accounts
        		                    8,500,000   
          consideration to danaher in connection with the separation
        		                       
          net cash from in financing activities
        		                       
          net cash from (used) in financing activities
        		                       
          net transfers from former parent
        		                       
          restructuring and impairment charges
        		                       
          proceeds from borrowings, net of deferred costs
        		                       
          payment for purchase of noncontrolling interest and related transactions
        		                       
          category
        		                       
          buildings
        		                       
          leased assets and leasehold improvements
        		                       
          machinery and equipment
        		                       
          net earnings
        		                       
          net proceeds from borrowings
        		                       
          net transfers to parent
        		                       
          supplemental disclosures:
        		                       
          cash income tax payments
        		                       
          cash interest payments